EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.6.4.B8 | Adenocarcinoma |
9933569 |
Human and mouse homologs of the Schizosaccharomyces pombe rad17+ cell cycle checkpoint control gene. |
ongoing research unassigned |
4 0 |
3.6.4.B8 | Ataxia |
27288435 |
Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction. |
causal interaction therapeutic application unassigned |
1 1 0 |
3.6.4.B8 | Ataxia |
30926972 |
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. |
unassigned |
0 |
3.6.4.B8 | Ataxia |
32582864 |
Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohort. |
ongoing research unassigned |
3 0 |
3.6.4.B8 | Ataxia |
32873692 |
Clinical spectrum of the pentanucleotide repeat expansion in the RFC1 gene in ataxia syndromes. |
causal interaction diagnostic usage ongoing research unassigned |
1 3 1 0 |
3.6.4.B8 | Ataxia |
33011895 |
Update on Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS). |
unassigned |
0 |
3.6.4.B8 | Ataxia Telangiectasia |
15235112 |
Chromatin association of rad17 is required for an ataxia telangiectasia and rad-related kinase-mediated S-phase checkpoint in response to low-dose ultraviolet radiation. |
unassigned |
0 |
3.6.4.B8 | Ataxia Telangiectasia |
18202016 |
Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine. |
causal interaction unassigned |
1 0 |
3.6.4.B8 | Ataxia Telangiectasia |
20177072 |
Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells. |
causal interaction ongoing research unassigned |
3 4 0 |
3.6.4.B8 | Ataxia Telangiectasia |
24358288 |
Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis. |
causal interaction therapeutic application unassigned |
4 3 0 |